Results 191 to 200 of about 877,912 (228)
Some of the next articles are maybe not open access.
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
Cardiology in Review, 1999Until the early 1990s, surgical myectomy was the standard treatment for patients with hypertrophic obstructive cardiomyopathy and drug refractory symptoms. In the past few years, the potential therapeutic options have dramatically changed with the introduction of DDD-pacemaker implantation and percutaneous transluminal septal myocardial ablation by ...
H, Seggewiss, L, Faber, P, Ziemssen
openaire +2 more sources
2016
Hypertrophic obstructive cardiomyopathy (HOCM) is a relatively common genetic disorder that exhibits wide variability in its clinical expression. Symptomatic patients most frequently experience exertional dyspnea, chest pain, fatigue and, occasionally, orthopnea or nocturnal dyspnea.
openaire +1 more source
Hypertrophic obstructive cardiomyopathy (HOCM) is a relatively common genetic disorder that exhibits wide variability in its clinical expression. Symptomatic patients most frequently experience exertional dyspnea, chest pain, fatigue and, occasionally, orthopnea or nocturnal dyspnea.
openaire +1 more source
Transradial alcohol septal ablation.
The Journal of invasive cardiology, 2015Radial access is shown to have fewer access-related complications when compared to femoral artery access. While two small European studies have examined the feasibility of transradial access for alcohol septal ablations, no reports from the United States have yet been published.
Luke P, Groben +2 more
openaire +1 more source
Surgical Septal Myectomy Versus Alcohol Septal Ablation
Circulation, 2014In hypertrophic cardiomyopathy (HCM), left ventricular (LV) outflow tract obstruction, caused by mitral valve systolic anterior motion (SAM) with elevated intracavitary LV pressures, can produce disabling symptoms of heart failure and excess cardiovascular mortality.1–7 Outflow gradients are common in HCM, present in 70% of patients at rest or with ...
Barry J, Maron, Rick A, Nishimura
openaire +2 more sources
Alcohol Septal Ablation in a Patient With Hypertrophic Obstructive Cardiomyopathy
Journal of Cardiothoracic and Vascular Anesthesia, 2014TRANSCORONARY ABLATION of septal hypertrophy (TASH), first introduced in 1994, has become an important option for treating symptomatic hypertrophic obstructive cardiomyopathy (HOCM), a rare disorder. The first septal branch of the left anterior descending artery (LAD) is located and 96% alcohol is instilled to induce an artificial myocardial infarction
Shvetank, Agarwal +2 more
openaire +2 more sources
Alcohol septal ablation after failed surgical myectomy
Catheterization and Cardiovascular Interventions, 2007AbstractWe describe the case of a successful alcohol septal ablation in a patient with persistent gradient and severe symptoms postsurgical myectomy. The alcohol ablation of the thickened septum abolished the left ventricular outflow gradient and the systolic anterior motion (SAM) of the mitral valve.
Dominique, Joyal +3 more
openaire +2 more sources
Alcohol Septal Ablation: Technique and Outcome
2014Dynamic left ventricular outflow tract obstruction is common in patients with hypertrophic cardiomyopathy, and can be associated with debilitating symptoms of heart failure. For those patients with drug-refractory symptoms, alcohol septal ablation is an effective therapy.
openaire +1 more source
[Alcohol septal ablation and hypertrophic cardiomyopathy].
Zhonghua xin xue guan bing za zhi, 2010Patients with hypertrophic cardiomyopathy who experience refractory symptoms due to left ventricular outflow tract obstruction are often referred for definitive therapy consisting of either surgical myectomy or alcohol septal ablation (ASA). There currently exists clinical equipoise regarding which therapy is the most efficacious in this challenging ...
Carey, Kimmelstiel +3 more
openaire +1 more source